Phase 1 Myeloma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are generally well enough to carry out daily activities with little to no limitation, as measured by a standard cancer health scale (a score of 0 or 1 on the ECOG scale).
- People who are expected to live for at least 12 weeks.
- People who have been diagnosed with multiple myeloma according to recognised international diagnostic standards.
- People whose multiple myeloma can be detected and measured through standard tests.
Who may not be able to join:
- People who have recently received chemotherapy or any other cancer treatment (including experimental treatments) and have not waited long enough since their last dose before starting the trial (confirm with trial site for specific waiting period required).
- People who have had a stem cell transplant using their own cells and have not waited long enough before the trial start date (confirm with trial site for specific waiting period required).
- People who have previously received a stem cell transplant using cells from another person (such as a donor).
- People who have previously had a transplant of a solid organ (such as a kidney, liver, or heart).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Clinical Trials, Hoffmann-La Roche
Phone: 888-662-6728 (U.S. and Canada)
Australian sites
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
1 site(s) in Australia. Confirm current status and contact details directly with the trial site.
Primary endpoints
Percentage of Participants With Adverse Events (AEs)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.